Clinical Trial Update: Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission [Phase 2]

View source ↗

Summary

Phase 2 results of difluoromethylornithine (DFMO) used as a preventative therapy in high-risk neuroblastoma patients in remission; the trial has completed and r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• Difluoromethylornithine (DFMO) (difluoromethylornithine)

Snippet

Sponsor: Giselle Sholler | Conditions: Neuroblastoma | Phase 2 | Status: COMPLETED | Results posted: 2020-04-03